E
PRTK

Ergoteles’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Ergoteles’s Portfolio PRTK Stock Details PRTK Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$49.7K Sell
2022
Q3 		$280K Sell
2022
Q2 		$440K Buy